Preincisional intraparietal Augmentin in abdominal operations

Area of Science:

• Surgical prophylaxis
• Infectious disease
• Pharmacology

Background:

• Surgical wound infections are a significant postoperative complication.
• Effective antibiotic prophylaxis is crucial in preventing surgical site infections.

Purpose of the Study:

• To compare the efficacy of two administration routes for amoxycillin/clavulanic acid in surgical wound infection prophylaxis.
• To determine if intraparietal injection is superior to intravenous injection.

Main Methods:

• A randomized controlled trial involving 624 patients undergoing abdominal operations.
• Patients received a single preoperative dose of amoxycillin/clavulanic acid (1.2 g Augmentin).
• Antibiotic was administered either intravenously (n=328) or subcutaneously along the incision line (n=296).

Main Results:

• The incidence of wound infections was significantly lower in the intraparietal injection group (8.4%) compared to the intravenous group (15.9%) (chi^2 = 7.90, P = 0.005).
• No significant differences were observed in other postoperative infectious or non-infective complications between the groups.

Conclusions:

• Preincisional intraparietal injection of amoxycillin/clavulanic acid is a more effective method for preventing surgical wound infections in abdominal surgery.
• This route offers improved prophylaxis compared to standard intravenous administration.